Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:17 PM
Ignite Modification Date:
2025-12-24 @ 11:17 PM
NCT ID:
NCT00264056
Eligibility Criteria:
Inclusion Criteria:
* age between 18 and 70
* histologically proven malignant melanoma with advanced inoperable soft tissue metastases
* progressive disease upon systemic first-line chemotherapy
* 2 or more bidimensionally measurable soft tisue lesions
* WHO performance status (ECOG) of 2 or more
* life expectancy of 8 weeks and more
* prior informed consent
Exclusion Criteria:
* participation in other therapy studies
* pregnancy or breast feeding
* concomitant clinically significant infection
* cardiac pacemaker or other medical implants, or implants within the hyperthermia treated region (including a safe distance of 5 cm)
* lack of physiological heat sensitivity within the hyperthermia treated region (including a safe distance of 5 cm)
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
70 Years
Study:
NCT00264056
Study Brief:
Protocol Section:
NCT00264056